Active TBS-DLPFC

DEVICE6 trials

Sponsors

Stanford University

Conditions

Treatment Resistant Depression

Unknown Phase

Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression (SAINT-TRD)

CompletedNCT03068715

Stanford UniversityTreatment Resistant Depression

Start: 2017-03-20End: 2021-01-09Updated: 2022-05-18

SAINT for Treatment of Preoperative Depression to Reduce Opioid Use Following Arthroplasty

WithdrawnNCT04195308

Stanford UniversityTreatment Resistant Depression

Start: 2024-06-30End: 2026-11-30Updated: 2022-12-14

Establishing a Dose-response Relationship With Accelerated Transcranial Magnetic Stimulation

CompletedNCT04243798

Stanford UniversityTreatment Resistant Depression

Start: 2021-06-15End: 2024-06-21Updated: 2026-03-30

Rapid Acting Transcranial Magnetic Stimulation

Active, not recruitingNCT04739969

Stanford UniversityTreatment Resistant Depression

Start: 2021-06-15End: 2025-12-31Target: 100Updated: 2025-05-06

Personalized Therapeutic Neuromodulation for Anhedonic Depression

CompletedNCT05144789

Stanford UniversityTreatment Resistant Depression

Start: 2022-05-31End: 2025-12-31Updated: 2026-07-29

Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression

Active, not recruitingNCT06052137

Stanford UniversityTreatment Resistant Depression

Start: 2023-12-19End: 2025-10-31Updated: 2025-04-04

Related Papers

Neurophysiological signatures of Stanford Neuromodulation Therapy in treatment resistant depression.

2026-09-02

Network effects of Stanford Neuromodulation Therapy (SNT) in treatment-resistant major depressive disorder: a randomized, controlled trial

Translational Psychiatry2023-07-0325 citations